Video Experimental Relacionado
Updated: Aug 9, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
Leishmania donovani: un microbio oportunista asociado con la enfermedad progresiva en tres pacientes
Lancet (London, England)
|March 22, 1986
Resumen
La Leishmania donovani puede causar enfermedad grave y progresiva en individuos inmunocomprometidos. Esta infección parasitaria, la leishmaniasis, puede surgir años después de la exposición, destacando su naturaleza oportunista.
Área de la Ciencia:
- Enfermedades infecciosas Enfermedades infecciosas.
- Inmunología Inmunología.
- Parasitología Parasitología.
Sus antecedentes:
- Leishmania donovani es un parásito conocido por causar leishmaniasis visceral.
- Los huéspedes inmunocomprometidos son susceptibles a las infecciones oportunistas.
- La exposición previa a Leishmania donovani puede no conferir una inmunidad duradera.
Objetivo del estudio:
- Para describir casos de enfermedad Leishmania donovani progresiva en huéspedes inmunocomprometidos.
- Para resaltar el potencial de supervivencia a largo plazo de Leishmania donovani.
Principales métodos:
- Análisis del informe de caso de tres pacientes con leishmaniasis progresiva.
- Revisión de los antecedentes médicos de los pacientes, incluidas las terapias inmunosupresoras y las condiciones coexistentes.
Principales resultados:
- Tres pacientes inmunocomprometidos desarrollaron una leishmaniasis progresiva.
- Los pacientes estaban en terapias que incluían corticosteroides, ciclofosfamida y cloramfenicol.
- Dos casos involucraron a individuos que habían abandonado las áreas endémicas años antes, lo que sugiere la supervivencia a largo plazo del parásito.
Conclusiones:
- La Leishmania donovani puede causar enfermedad progresiva en huéspedes inmunocomprometidos.
- El parásito puede permanecer latente durante largos períodos en el huésped.
- La Leishmania donovani debe ser reconocida como un patógeno oportunista.
Videos de Conceptos Relacionados
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

